Physician profile
Melissa Johnson
NPI 1184618654
$659.84
in general payments reported to CMS, 2019-2025
14 companies · $505 in 2025
The $505 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $21.56 · 2024: $133 · 2025: $505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $638.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $142.49 | 2024-2025 | Ozempic, Rybelsus |
| Sage Therapeutics, LLC | $126.14 | 2024-2025 | Zurzuvae |
| Dexcom, INC. | $63.53 | 2024-2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $55.38 | 2024-2025 | |
| Alk-Abello, INC | $50.61 | 2025 | Grastek, Odactra, Ragwitek |
| Supernus Pharmaceuticals, INC. | $45.27 | 2025 | Qelbree |
| Viiv Healthcare Company | $32.89 | 2025 | Apretude |
| Organon LLC | $25.98 | 2024 | |
| Exact Sciences Corporation | $22.58 | 2025 | Cologuard Collection Kit |
| Abbvie INC. | $21.56 | 2022 | |
| Hologic Sales and Service, LLC | $21.13 | 2025 | Aptima |
| Pfizer INC. | $19.25 | 2025 | |
| Glaxosmithkline, LLC. | $17.72 | 2025 | Nucala |
| Paratek Pharmaceuticals, INC. | $15.31 | 2025 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.